期刊文献+

p16基因表达与胃癌组织类型的关系 被引量:1

Relationship between the Expression of p16 Gene and the Phenotypes of Human Gastric Carcinomas
暂未订购
导出
摘要 探讨P16基因的表达与人胃癌组织类型的关系。方法:选取24例病理确诊的胃癌组织及相应正常胃粘膜组织,用蛋白质免疫印迹(Westernblot)做术检测p16基因在两种组织中的表达。结果:24例胃癌组织中,6例无p16基因表达的癌组织为低分化腺癌或印戒细胞癌;2例p16基因表达可疑;分化较高的5例p16基因表达增多;其余11例p16基因的表达同相应正常组织无区别。结论:p16基因在胃癌组织中的表达既可减低,也可增加,相当一部分胃癌组织p16基因的表达同相应正常组织无明显区别;p16基因表达减低的病例,其病理学诊断往往属于恶性程度较高的低分化腺癌或印戒细胞癌,可能与患者的预后有一定关系。 Background/Aims: To study the relationship between the expression of p16 gene and the phenotypes of human gastric carcinomas. Methods: 24 human gastric carcinoma specimens and the adjacent normal gastric mucosal tissues were determined by molecular pathologic methods. The expression of p16 gene was studied by Western blot assay. Results: Deleted p16 gene expression was found in 6 poorly-differentiated adenocarcinomas or signet ring cell carcinomas among the 24 human gastric carcinomas, in two, the p16 gene expression was suspicious, and in 5 well-differentiated carcinomas, it was over-expressed, while in the rest of 11 cases, there were no differences between cancer tissue and the normal gastric mucosal tissue. Conclusions: The expression of p16 gene in human gastric carcinomas may be either decreased or increased, and in many cases, the gastric carcinomatous tissue showed no difference as compared with the adjacent normal gastric mucosal tissue; the cases of decreased expression of p16 gene always belong to the poorly-differentiated ones or the signet ring cell carcinomas,which might be related to their poor prognosis.
出处 《胃肠病学》 2000年第2期107-108,115,共3页 Chinese Journal of Gastroenterology
关键词 胃肿瘤 基因表达 基因 P16 Stomach Neoplasms Gene Expression Genes, p16
  • 相关文献

参考文献8

  • 1Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ, Sidransky D. A novel p16INK4A transcript. Cancer Res, 1995, 55: 2995~2997.
  • 2Igaki H, Sasaki H, Tachimori Y, Kato H, Watanabe H, Kimura T, Harada Y, Sugimura T, Terada M. Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract. Cancer Res, 1995, 55: 3421~3423.
  • 3[美]J萨姆布鲁克.分子克隆实验指南.金冬雁,黎孟枫,译.北京:中国科学出版社,1986.881-898.
  • 4Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 1993, 366:704~707.
  • 5Linardopoulos S, Street AJ, Quelle DE, Parry D,Peters G, Sherr CJ, Balmain A. Deletion and altered regulation of p16INK4a and p16INK4b in undifferentiated mouse skin tumors. Cancer Res, 1995,55: 5168~5172.
  • 6Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 1994, 368: 753~756.
  • 7Yang R, Gombart AF, Serrano M, Koeffier HP.Mutational effects on the p16INK4a tumor suppressor protein. Cancer Res, 1995, 55: 2503~2506.
  • 8Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J. Retinoblastomaprotein-dependent cell-cycle inhibition by the tumor suppressor p16. Nature, 1995, 375: 503~506.

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部